Forecast Period | 2024-2028 |
Market Size (2022) | USD 1.52 Billion |
CAGR (2023-2028) | 5.25% |
Fastest Growing Segment | Immunodiagnostics |
Largest Market | North America |
Market Overview
Global Veterinary Infectious Disease Diagnostics Market
The increasing incidence of zoonotic diseases has raised awareness about the interconnectedness of animal and human health. Diseases such as avian influenza, brucellosis, and leptospirosis can be transmitted between animals and humans, emphasizing the need for robust diagnostic tools.
Key Market Drivers
Increasing Pet Ownership and Humanization of Pets is Driving the Global Veterinary Infectious Disease Diagnostics Market
In recent years, there has been a notable global shift in the way people perceive and care for their pets. The increasing trend of pet ownership and the growing humanization of pets have not only led to an upsurge in spending on pet healthcare but have also been significant drivers of the veterinary infectious disease diagnostics market. This market, which plays a crucial role in ensuring the health and well-being of animals, has witnessed unprecedented growth as pet owners seek advanced diagnostic solutions for their beloved companions. The worldwide surge in pet ownership is a multifaceted phenomenon, influenced by factors such as urbanization, changing lifestyles, and an increased understanding of the emotional and physical benefits that pets bring to their owners. As more people open their homes to pets, whether they be dogs, cats, birds, or exotic animals, the demand for comprehensive veterinary care has risen significantly.
This burgeoning population of pets has given rise to a corresponding demand for advanced diagnostic tools to detect and manage infectious diseases. Veterinary infectious disease diagnostics encompass a range of tests and procedures that aid in the identification and monitoring of diseases in animals. These diagnostics not only help in the early detection of illnesses but also play a crucial role in preventing the spread of infectious diseases among animals and, in some cases, to humans.
The increasing humanization of pets is another major trend shaping the veterinary infectious disease diagnostics market. Pet owners are now more inclined to view their animals as integral members of the family, leading to a greater willingness to invest in their health and well-being. This paradigm shift has translated into higher expectations for the quality of veterinary care, including advanced diagnostics, and has fueled the growth of the global market. Pet owners are seeking not just basic veterinary services but also cutting-edge diagnostics that can provide more accurate and timely results. This shift in consumer behaviour has prompted veterinary diagnostic companies to innovate and develop new technologies and testing methods to meet the evolving demands of pet owners.
Rising Incidence of Zoonotic Diseases is Driving the Global Veterinary Infectious Disease Diagnostics Market
Zoonotic diseases, which are infections that can be transmitted between animals and humans, have garnered increased attention in recent years due to their potential for rapid spread and devastating impact on both animal and human populations. The rise in these diseases has led to a growing demand for effective diagnostic tools, driving the expansion of the global veterinary infectious disease diagnostics market
The interconnectedness of animal and human health is increasingly recognized as a crucial aspect of global health. As human populations expand and encroach on natural habitats, the risk of zoonotic disease transmission escalates. Climate change, international travel, and the global movement of goods further contribute to the complexity of disease transmission dynamics.
Key Market Challenges
High Cost of Diagnostic Equipment
The field of veterinary diagnostics plays a crucial role in safeguarding the health of animals and preventing the spread of infectious diseases. As technology continues to advance, the demand for accurate and timely diagnostics in the veterinary sector has grown exponentially. However, one formidable challenge hindering the progress of the Global Veterinary Infectious Disease Diagnostics Market is the exorbitant cost associated with diagnostic equipment
Veterinary clinics and laboratories, facing the burden of expensive diagnostic equipment, may struggle to invest in the latest technologies. The financial strain on these establishments not only affects their ability to provide cutting-edge services but also impacts their competitiveness in the market.
Key Market Trends
Technological Advancements
In recent years, the global veterinary industry has experienced a significant transformation, with a sharp focus on technological advancements to address the challenges posed by infectious diseases in animals. The Veterinary Infectious Disease Diagnostics Market has witnessed a remarkable surge, driven by cutting-edge technologies that are revolutionizing the way diseases are diagnosed and treated in animals
Segmental Insights
Technology Insights
Based
Animal Type Insights
The Companion Animals segment is projected to experience rapid growth during the forecast period. Companion animals, which include pets like dogs, cats, and horses, have become integral members of households worldwide. The deep emotional bonds shared between humans and their furry friends have elevated the status of these animals from mere pets to cherished family members. As the number of companion animals continues to rise globally, so does the concern for their health and well-being
Regional Insights
North America emerged as the dominant player in the global Veterinary Infectious Disease Diagnostics market in 2022, holding the largest market share in terms of value. North America, particularly the United States and Canada, has been at the forefront of technological innovation in the healthcare and diagnostics industries. The region's commitment to research and development has resulted in cutting-edge diagnostic tools and techniques, enabling more accurate and timely identification of infectious diseases in animals. The rising trend of pet ownership in North America has led to a surge in demand for advanced veterinary diagnostics. Pet owners are increasingly investing in the health and well-being of their animals, driving the need for sophisticated diagnostic tools to identify and manage infectious diseases effectively.
Recent Developments
- In April 2021, INDICAL BIOSCIENCE GmbH, a Germancompany, expanded its portfolio by acquiring Boehringer Ingelheim's Svanovaproduct portfolio. This acquisition enabled INDICAL to incorporate 25 livestockassays into its range of offerings.
- In January 2021, the US-based Heska Corporationsuccessfully acquired Lacuna Diagnostics, thereby enhancing its range ofpoint-of-care digital cytology technology and telemedicine services.
Key Market Players
- BIOMÉRIEUX
- HeskaCorporation
- NeogenCorporation
- INDICALBIOSCIENCE GmbH
- RandoxLaboratories Ltd.
- ThermoFisher Scientific Inc.
- CreativeDiagnostics
- DRGINSTRUMENTS GMBH
- ChembioDiagnostic Systems, Inc.
- EurofinsTechnologies
- Agrolabo S.p.A.
- AbbottLaboratories inc.
- DanaherCorporation
By Technology | By Animal Type | By End user | By Region |
- Immunodiagnostics
- Molecular Diagnostics
- Other Veterinary Diagnostic Technologies
| - Companion Animals
- Food Producing Animals
| - Reference Laboratories
- Veterinary Laboratories and Clinics
- Point of Care / In House Testing
- Research Institutes and Universities
| - North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
|